Bank of America
IBIO icon

Bank of America’s iBio IBIO Stock Holding History

Bank of America’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$552K Buy
290,413
+174,620
+151% +$405K ﹤0.01% 4841
2025
Q4 		$223K Buy
115,793
+115,648
+79,757% +$158K ﹤0.01% 5289
2025
Q3 		$120 Sell
145
-12
-8% -$9 ﹤0.01% 7818
2025
Q2 		$120 Buy
157
+73
+87% +$79 ﹤0.01% 7938
2025
Q1 		$338 Buy
84
+10
+14% +$39 ﹤0.01% 7588
2024
Q4 		$181 Buy
74
+3
+4% +$8 ﹤0.01% 7612
2024
Q3 		$158 Hold
71
– – ﹤0.01% 7617
2024
Q2 		$150 Buy
+71
New +$153 ﹤0.01% 7624
2023
Q1 		– Sell
-1
Closed -$6 – 8006
2022
Q4 		$6 Buy
+1
New +$34 ﹤0.01% 8125
2022
Q3 		– Sell
-1
Closed -$138 – 8005
2022
Q2 		$0 Sell
1
-72
-99% -$10.8K ﹤0.01% 8172
2022
Q1 		$16K Sell
73
-162
-69% -$33.9K ﹤0.01% 7608
2021
Q4 		$65K Buy
235
+58
+33% +$22.1K ﹤0.01% 7086
2021
Q3 		$94K Buy
177
+45
+34% +$28K ﹤0.01% 6755
2021
Q2 		$100K Sell
132
-451
-77% -$329K ﹤0.01% 6521
2021
Q1 		$449K Buy
583
+506
+657% +$441K ﹤0.01% 5458
2020
Q4 		$40K Buy
77
+65
+542% +$53K ﹤0.01% 6401
2020
Q3 		$13K Sell
12
-38
-76% -$55.1K ﹤0.01% 6381
2020
Q2 		$55K Buy
50
+10
+25% +$6.54K ﹤0.01% 5945
2020
Q1 		$21K Buy
40
+19
+90% +$7.31K ﹤0.01% 6160
2019
Q4 		$3K Buy
+21
New +$2.85K ﹤0.01% 6834
2019
Q1 		– Hold
0
– – – 7237
2018
Q4 		– Sell
-5
Closed -$1.93K – 7217
2018
Q3 		$2K Buy
+5
New +$2.02K ﹤0.01% 7017
2018
Q2 		– Sell
-1
Closed -$1K – 7189
2018
Q1 		$1K Hold
1
– – ﹤0.01% 6964
2017
Q4 		$1K Buy
+1
New +$1.28K ﹤0.01% 6916
2017
Q3 		– Hold
0
– – – 7145
2017
Q2 		– Hold
0
– – – 7040
2017
Q1 		– Hold
0
– – – 7094
2016
Q4 		– Hold
0
– – – 7155
2016
Q3 		– Hold
0
– – – 7213
2016
Q2 		– Sell
-2
Closed -$6.53K – 7220
2016
Q1 		$4K Buy
+2
New +$5.73K ﹤0.01% 6635
2014
Q3 		– Hold
0
– – – 8072
2014
Q2 		– Hold
0
– – – 8096
2014
Q1 		– Hold
0
– – – 7921
2013
Q4 		– Hold
0
– – – 7987
2013
Q3 		– Hold
0
– – – 7940
2013
Q2 		– Hold
0
– – – 7716

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Bank of America's IBIO Position: Q1 2026 in Review

Bank of America increased its iBio (IBIO) stake by 151% in Q1 2026, buying an estimated $405K and bringing the position to 290,413 shares worth $552K. The position accounts for ﹤0.01% of the portfolio, ranked #4841.

Bank of America first reported a position in IBIO in Q1 2016 and has held it in 24 quarters since. 52 funds tracked by Wall St. Rank hold IBIO as of Q1 2026.

  • Bank of America held 290,413 shares of iBio worth $552K as of Q1 2026.
  • Bank of America bought 174,620 iBio shares in Q1 2026, an estimated $405K.
  • iBio made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4841 holding.
  • Bank of America first reported a position in iBio in Q1 2016 and has held it in 24 quarters since.
  • 52 funds tracked by Wall St. Rank held iBio as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.